TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Xxlofoten AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
27,566
|
25,353
|
16,029 |
Financial expenses |
421
|
335
|
413 |
Earnings before taxes |
5,026
|
4,879
|
4,480 |
Total assets |
20,913
|
27,464
|
22,613 |
Current assets |
10,754
|
13,611
|
10,447 |
Current liabilities |
7,579
|
1,851
|
1,896 |
Equity capital |
6,420
|
17,560
|
12,685 |
- share capital |
3,661
|
3,921
|
3,803 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.7%
|
63.9%
|
56.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.2%
|
19.2%
|
27.9% |
Return on assets (ROA) |
26.0%
|
19.0%
|
21.6% |
Current ratio |
141.9%
|
735.3%
|
551.0% |
Return on equity (ROE) |
78.3%
|
27.8%
|
35.3% |
Change turnover |
3,892
|
8,827
|
6,473 |
Change turnover % |
16%
|
53%
|
68% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.